Brucellosis: Morphofunctional Correlation and Immune Response in Brucella Infection

Authors

DOI:

https://doi.org/10.63688/ds481k45

Keywords:

Brucellosis, immune response, morphofunctional correlation, spondylitis, bird genomics

Abstract

Few infectious diseases combine high global prevalence with such low clinical recognition as brucellosis, a neglected bacterial zoonosis with an estimated 2.1 million new cases annually. The causative agent, Brucella, is a facultative intracellular Gram-negative coccobacillus that survives within macrophages by blocking phagolysosomal fusion via its type IV secretion system, establishing a replicative niche in the endoplasmic reticulum. This systematic review (PRISMA protocol) analyzes 11 studies on the morphofunctional correlation and immune response in the infection. The results show that T2-weighted magnetic resonance imaging differentiates brucellar spondylitis from tuberculous spondylitis, with significantly higher values ​​(p<0.001). The SSC classification allows for severity stratification and treatment guidance, with improvement in ESR and CRP at six months. Subsequent surgical intervention better corrects kyphosis with a shorter surgical time. Relapse (12.2%) is associated with advanced age, female sex, and agricultural occupation, not with focal complications. Hematological findings include anemia (25.9%), monocytosis (15.9%), and eosinopenia (10.3%). Children present with more bacteremia and peripheral arthritis; adults, with greater vertebral involvement. Genomic analysis reveals an open pan-genome with 21,800 gene families and resistance and virulence genes, indicating genetic plasticity of the genus. The integration of morphofunctional and immunological findings allows for a clinically useful pathophysiological approach.

References

1. Guo H, Lan S, He Y, Tiheiran M, Liu W. Differentiating brucella spondylitis from tuberculous spondylitis by conventional MRI and MR T2 mapping: a prospective study. Eur J Med Res. 2021;26(1):122. PMID: 34711265. https://doi.org/10.1186/s40001-021-00598-4

2. Liu X, Zhang R, Sun M, Qiao J, Liang M. Comparative genomics of Brucella species reveals determinants of resistance and virulence. Sci Rep. 2025;16(1):Article 41466046. PMID: 41466046. https://doi.org/10.1038/s41598-025-33824-8

3. Fica A, et al. Serologic evidence of zoonotic infections caused by Brucella canis in humans. Rev Med Chil. 2025;153(10):695–707. PMID: 41021857.

4. Na P, Mingzhi Y, Yin X, Chen Y. Surgical treatment for lumbar brucella spondylitis using posterior approach. Medicine (Baltimore). 2021;100(21):e26076. PMID: 34032738. https://doi.org/10.1097/md.0000000000026076

5. Zou Y, et al. Clinical characteristics and differential diagnosis between neurobrucellosis and tuberculous meningitis. BMC Neurol. 2024;24(1):Article 38664634. PMID: 38664634.

6. Ma L, et al. Comparison of clinical features between pediatric and adult brucellosis patients. J Infect Dev Ctries. 2021;15(8):1147–54. PMID: 34516423.

7. Dadar M, et al. Risk factors associated with relapse and focal complications in brucellosis patients. Int J Infect Dis. 2025;160:108047. PMID: 40915348.

8. Hassan KS, et al. Clinical manifestations and outcomes of human brucellosis. Sultan Qaboos Univ Med J. 2021;21(2):e282–8. PMID: 34221477.

9. Çelik M, et al. Hematologic findings associated with brucellosis infection. Saudi Med J. 2024;45(5):495–501. PMID: 38734423. https://doi.org/10.15537/smj.2024.45.5.20230847

10. Jeyaraman N, et al. Management classification system for spinal brucellosis. Travel Med Infect Dis. 2023;54:102614. PMID: 37392982.

11. Celik M, et al. Testicular involvement in brucellosis: clinical and diagnostic features. J Infect Dev Ctries. 2023;17(9):1285–91. PMID: 37824350. https://doi.org/10.3855/jidc.18084

12. Esmaeilnejad-Ganji SM, Esmaeilnejad-Ganji MR. Osteoarticular manifestations of human brucellosis: a review. World J Orthop. 2019;10(2):54–62. PMID: 30788235. https://doi.org/10.5312/wjo.v10.i2.54

13. Unuvar GK, et al. Research progress on complications of human brucellosis. Front Cell Infect Microbiol. 2023;13:1106752. PMID: 37065196.

14. Weese JS, Weese HE. Brucellosis in humans caused by Brucella canis: a scoping review. Can Vet J. 2025;66. PMCID: PMC11891790. https://pmc.ncbi.nlm.nih.gov/articles/PMC11891790/

15. Chen X, et al. Incidence and warning signs of complications in human brucellosis. Infect Dis Poverty. 2024;13:Article 1186. doi:10.1186/s40249-024-01186-4.

16. Soares CN, da Silva MT, Lima MA. Neurobrucellosis: clinical and diagnostic aspects. Curr Opin Infect Dis. 2023;36. PMID: 37093043. https://doi.org/10.1097/qco.0000000000000920

17. Kayaaslan B, et al. Osteoarticular involvement and relapse in brucellosis. Mediterr J Infect Microb Antimicrob. 2020;9. doi:mjima.galenos.2020.2020.1.

Downloads

Published

2026-03-20

How to Cite

Carate Guagchinga, P. E., Aguiar Villamar, N. L., Guevara Cusangua, L. A., Tabuada Nuñez, C. A., & Rojano Parra, E. A. (2026). Brucellosis: Morphofunctional Correlation and Immune Response in Brucella Infection. Sage Sphere of Technology, Sciences, Discoveries And Society, 4(1), 1-21. https://doi.org/10.63688/ds481k45